» Articles » PMID: 33230457

MiR-4721, Induced by EBV-miR-BART22, Targets to Enhance the Tumorigenic Capacity of NPC Through the Pathway

Overview
Publisher Cell Press
Date 2020 Nov 24
PMID 33230457
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Nasopharyngeal carcinoma (NPC) is prevalent in East and Southeast Asia. In a previous study, Epstein-Barr virus (EBV)-miR-BART22 induces tumor metastasis and stemness and is significantly involved in NPC progression. In the present study, we observed that miR-4721 is induced by EBV-miR-BART22 through phosphatidylinositol 3-kinase (PI3K)/AKT/c-JUN/Sp1 signaling to promote its transcription. In a subsequent study, we observed that miR-4721 serves as a potential oncogenic factor promoting NPC cell cycle progression and cell proliferation and . Mechanism analysis indicated that miR-4721 directly targetes GSK3β and reduces its expression, which therefore elevates β-catenin intra-nuclear aggregation and activates its downstream cell cycle factors, including CCND1 and c-MYC. In clinical samples, miR-4721 and GSK3β are respectively observed to be upregulated and downregulated in NPC progression. Elevated expression of miR-4721 is positively associated with clinical progression and poor prognosis. Our study first demonstrated that miR-4721 as an oncogene is induced by EBV-miR-BART22 via modulating PI3K/AKT/c-JUN/Sp1 signaling to target GSK3β, which thus activates the WNT/β-catenin-stimulated cell cycle signal and enhances the tumorigenic capacity in NPC. miR-4721 may be a potential biomarker or therapeutic target in NPC treatment in the future.

Citing Articles

FOXA1, induced by RC48, regulates HER2 transcription to enhance the tumorigenic capacity of lung cancer through PI3K/AKT pathway.

Zhao M, Zhang N, Wang Y, Han K, Gao T, Li X J Cancer. 2024; 15(18):5863-5875.

PMID: 39440051 PMC: 11493013. DOI: 10.7150/jca.100210.


Unique lipid composition maintained by extracellular blockade leads to prooncogenicity.

Kudo K, Yanagiya R, Hasegawa M, Carreras J, Miki Y, Nakayama S Cell Death Discov. 2024; 10(1):221.

PMID: 38719806 PMC: 11079073. DOI: 10.1038/s41420-024-01971-y.


Novel plasma microRNA expression features in diagnostic use for Epstein-Barr virus-associated febrile diseases.

Xu Y, Chen Y, Yang Q, Lu Y, Zhou R, Liu H Heliyon. 2024; 10(5):e26810.

PMID: 38444478 PMC: 10912469. DOI: 10.1016/j.heliyon.2024.e26810.


Comprehensive insight into altered host cell-signaling cascades upon Helicobacter pylori and Epstein-Barr virus infections in cancer.

Kashyap D, Rele S, Bagde P, Saini V, Chatterjee D, Jain A Arch Microbiol. 2023; 205(7):262.

PMID: 37310490 DOI: 10.1007/s00203-023-03598-6.


Bioinformatic analysis confirms differences in circular RNA expression profiles of cumulus cells between patients with ovarian and peritoneal endometriosis-associated infertility.

Huang X, Yu Q Front Endocrinol (Lausanne). 2023; 14:1137235.

PMID: 37008951 PMC: 10050890. DOI: 10.3389/fendo.2023.1137235.


References
1.
Tang H, Lai Y, Zheng J, Chen K, Jiang H, Xu G . MiR-146a Promotes Tolerogenic Properties of Dendritic Cells and through Targeting Notch1 Signaling. Immunol Invest. 2020; 49(5):555-570. DOI: 10.1080/08820139.2019.1708385. View

2.
Xu Y, Zhou R, Zong J, Lin W, Tong S, Guo Q . Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2/NF-κB pathway. Cancer Lett. 2019; 447:33-40. DOI: 10.1016/j.canlet.2019.01.022. View

3.
Cheng S, Zhou F, Xu Y, Liu X, Zhang Y, Gu M . Geniposide regulates the miR-101/MKP-1/p38 pathway and alleviates atherosclerosis inflammatory injury in ApoE mice. Immunobiology. 2019; 224(2):296-306. DOI: 10.1016/j.imbio.2018.12.005. View

4.
Lee S, Yang J, Park J, Shin H, Kim W, Kim S . The MicroRNA-92a/Sp1/MyoD Axis Regulates Hypoxic Stimulation of Myogenic Lineage Differentiation in Mouse Embryonic Stem Cells. Mol Ther. 2019; 28(1):142-156. PMC: 6951826. DOI: 10.1016/j.ymthe.2019.08.014. View

5.
Law C, Wei L, Tsang F, Chan C, Xu I, Lai R . HELLS Regulates Chromatin Remodeling and Epigenetic Silencing of Multiple Tumor Suppressor Genes in Human Hepatocellular Carcinoma. Hepatology. 2018; 69(5):2013-2030. DOI: 10.1002/hep.30414. View